Ivana serves as Vice President of Product for Corporate Markets at Elsevier, overseeing a portfolio that encompasses everything from drug discovery and development to pharmacovigilance, and has led the group for the past five years. Ivana is passionate about harnessing cutting-edge technology and Elsevier’s uniquely broad and deep data assets to help customers deliver lifesaving medications to patients more efficiently. She has been part of the RELX team for 16 years and hold a PhD in Pharmacology.